
Maybe It’s NOT Mechanical Back Pain
Getting on the Fast Track to Identify AxSpA
Apple Books | Amazon | Barnes & Noble | Google Play | Rakuten Kobo
Education and Training Opportunities
Spondylitis Association of America (SAA)
Spondylitis Resources and Information for Medical Professionals
The SAA shares your goal of helping patients achieve optimum health. They offer support for and appreciation of your work and special interest in spondyloarthritis — a too often forgotten and widely underdiagnosed inflammatory rheumatic disease.
Demystifying Axial Spondyloarthritis in Primary Care: Recognition, Diagnosis, and What Comes Next
EMS Pitfalls: Ankylosing Spondylitis
American College of Rheumatology (ACR)
Expand your knowledge, connect with colleagues and earn CME credits and MOC points with the ACR’s broad range of educational activities, including live meetings and online courses.
Primary Spine Practitioner (PSP) Certification Program
University of Pittsburgh
Advanced Clinician Practitioner in Arthritis Care (ACPAC)
Temerty Faculty of Medicine, University of Toronto
Clinical Practice Guidelines
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM, et al. Arthritis Rheumatol. 2019;71(10):1599-1613.
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
van der Heijde D, et al. Ann Rheum Dis. 2017;76(6):978-991.
Clinical Resources
SAA Clinical Pocket Guide for Axial Spondyloarthritis (axSpA)
Patient Resources
Serving the Spondyloarthritis Community
SAA is a nationwide nonprofit organization that educates, empowers, and advocates for people living with spondylitis and its related diseases. Through its partnership with patients and the medical community, SAA provides extensive resources and champions research to find a cure.
CreakyJoints
Global Healthy Living Foundation
CreakyJoints provides a digital worldwide community for patients with arthritis and their caregivers. Free-of-charge programming and services include education, support, advocacy, and patient-centered research.
Project Nightingale
The Nightingale study is designed to empower people with AxSpA to take control of their symptoms and improve their quality of life. Real-time data gathered via the uMotif app tracks exercise, sleep, and other factors, allowing a level of disease self-management.
Suggested Readings
Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities.
Danve A, Deodhar A. Clin Rheumatol. 2019;38(3):625-634.
Axial spondyloarthritis in the chiropractic care setting: a systematic literature review.
Deodhar A, et al. J Clin Rheumatol. 2021. doi:10.1097/RHU.0000000000001776.
Choose wisely: imaging for diagnosis of axial spondyloarthritis.
Diekhoff T, et al. Ann Rheum Dis. 2021;0:1-6.
Primary care physician perspectives on barriers to diagnosing axial spondyloarthritis: a qualitative study.
Lapane KL, et al. PLoS One. 2021;16(5):e0252018.
Recognizing axial spondyloarthritis: a guide for primary care.
Magrey MN, et al. Mayo Clin Proc. 2020;95(11):2499-2508.
The American College of Rheumatology fibromyalgia criteria are useful in the evaluation of fibromyalgia symptoms in patients with ankylosing spondylitis: a cross-sectional study.
Magrey MN, et al. J Clin Rheumatol. 2021;27(8):e399-e403.
Physical therapy in axial spondyloarthritis: guidelines, evidence and clinical practice.
Martey C, Sengupta R. Curr Opin Rheumatol. 2020;32(4):365-370.
The journey to diagnosis in AS/axial SpA: the impact of delay.
Martindale J, Goodacre L. Musculoskelet Care. 2014;12(4):221-231.
Comparison of men and women with axial spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ, et al. J Rheumatol. 2021;48(10):1528-1536.
Treatment of axial spondyloarthritis: What does the future hold?
Poddubnyy D, Sieper J. Curr Rheumatol Rep. 2020;22(9):47.
The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study.
Redeker I, et al. Arthritis Res Ther. 2020;22(1):210.
Axial spondyloarthritis: new advances in diagnosis and management.
Ritchlin C, Adamopoulos IE. BMJ. 2021;372:m4447.
Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging, and therapy.
Robinson PC, et al. Rheumatol Ther. 2019;6(2):165-177.
High-intensity exercise improves fatigue, sleep, and mood in patients with axial spondyloarthritis: secondary analysis of a randomized controlled trial.
Sveaas SH, et al. Phys Ther. 2020;100(8):1323-1332.
Mechanical low back pain.
Will JS, et al. Am Fam Physician. 2018;98(7):421-428.

Looking for something to share with your patient with newly diagnosed – or suspected – AxSpA?
Be sure to request your copies of the hand-held patient/provider education and discussion tool: Is This Inflammatory Back Pain? Get on the Fast Track to Identifying Axial Spondyloarthritis (AxSpA)
A Multimedia eHealth Source™ Educational Initiative
Relevant Resources
Improved Diagnostic and Management Strategies
Balancing the Benefits and Risk of Opioid-Based Therapy
Individualized Assessment and Mechanism-Based Multimodal Treatment
Responsible Opioid Prescribing to Achieve Individualized Functional Goals
Long-Term Management Strategies to Improve Patient Outcomes
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Proactive Diagnosis and Targeted Management
Selecting Patients and Optimizing Long-Term Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
The Role of Nurses in Optimizing Long-term Outcomes
Evolving Approaches to Insulin Based Therapy
Evolving Best-Practice Strategies to Maximize Efficacy and Safety
Treating to Target, IL-6-Directed Therapies, and Evolving Management Algorithms
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Patient Selection, Treatment Initiation, and Ongoing Monitoring
Pathophysiology to the Management of Moderate-to-Severe Disease
Engaging With Patients About Opioid-Induced Constipation
Evolving Best Practices to Optimize Outcomes
Targeting Immune Dysregulation and Delivering Comprehensive Care
The PCP’s Role in Timely Recognition and Referral
Translating Comprehensive Patient Evaluations Into Personalized Therapy
Looking Beyond Barriers to Optimize Therapy
New Perspectives on Targeting Remission and Individualizing Therapy
Using Imaging to Improve Patient Outcomes
Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling
Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
Expanding the Conversation on Opioid-Induced Constipation
Translating Pathophysiology into Targeted Treatments
Think You Know JAK?
An Interactive Experience Highlighting Recent Clinical Advances
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Debates & Discussions on the Evolving Role of JAK Inhibitors
Translating Guidelines Into Patient Care
Improving Patient Outcomes Through Shared Clinical Decision Making
Mechanistic Insights and Evolving Treatment Options
Clinical Resource Center
The Evolving Role of JAK Inhibitors
Unpacking the Evidence for Their Use Today and Tomorrow
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
A PrEP Primer
A Foundation for Managed Care
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
What the Pharmacist Needs to Know about PrEP
Unlocking Novel Paths to Patient Care
The Increasing Role of JAK Inhibitors
Unlocking Novel Paths to Patient Care
New Pathways to Patient Management
A Focus on Clinical Evidence and Guideline Recommendations
Preventing COPD Exacerbations to Improve Outcomes
A Whole Patient Case Series
New Avenues to the Management of Severe Asthma
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
Reducing LDL-C and a Lifetime of Cardiovascular Risk
Updates, Clinical Scenarios, and Future Directions
A Multidisciplinary Look at Early Diagnosis and Management
Finding the Path in Chronic Rhinosinusitis with Nasal Polyps
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
Are You Aware of New Blood-Based Multi-Cancer Screening Tools
From Patient Evaluations to New Targeted Therapies
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Strengthening Your Knowledge of Blood-Based Screening Tools
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
What You Need to Know About New Blood-Based Screening Tools
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
New Avenues to Improve Patient Outcomes
Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis
Practical Updates on the 2023 GOLD Guidelines
A Phone-a-Friend CME Series – Volume 2
Best Practices for Screening, Diagnosis, and Management
Incorporating New Data and Updated Guidelines Into Daily Practice
Focus on Psoriasis
Capitalizing on BCMA-Directed Therapies
From the Airway Epithelium to Improved Patient Outcomes
Exercising Best Practices for Hospitalized Patients
Accelerating Diagnosis and Treatment